Search

Issue
Title
Authors
Prognostic factors in patients with hematological malignancies and concomitant chronic hepatitis C
Nozhkin M.S., Lioznov D.A., Antonova T.V., Gorchakova O.V., Goldstein E.M., Popova M.O., Shneyder T.V.
Efficacy and safety of bulevirtide in patients with chronic hepatitis D and compensated cirrhosis
Bogomolov P.O., Ivashkin V.T., Bueverov A.O., Maev I.V., Sagalova O.I., Sleptsova S.S., Yushuk N.D., Gusev D.A., Zhdanov K.V., Chulanov V.P.
Chronic hepatitis B in rheumatic diseases: issues of screening and reactivation of infection: A review
Gridneva G.I., Belov B.S., Aronova E.S.
Assessment of body mass index in patients with chronic hepatitis C who received an effective antiviral therapy
Dudina K.R., Belyy P.A., Maev I.V., Klimova E.A., Shutko S.A., Znoyko O.O., Yuschuk N.D.
Comparative evaluation of the effectiveness of narlaprevir in the composition of interferon and interferon-free treatment regimens for patients with chronic hepatitis C
Grushko I.P., Romanova E.B., Tverdokhlebova T.I., Gapon M.N., Vodyanitskaya S.Y.
The clinical and hemostasiological features of chronic hepatitides of different genesis
Bilalova A.R., Makashova V.V., Astrina O.S., Aleshina N.I., Florianu A.I.
The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia
Pimenov N.N., Vdovin A.V., Komarova S.V., Mamonova N.A., Chulanov V.P., Pokrovskiĭ V.I.
A variety of extrahepatic manifestations of chronic viral hepatitis B and C: basic treatment principles
Baĭkova T.A., Lopatkina T.N.
Role of transforming growth factor-beta in the development of some liver diseases
Raĭkhel'son K.L., Karev V.E., Marchenko N.V., Semenov N.V., Pal'gova L.K., Baranovskiĭ A.I.
Hepatitis C virus - related cryoglobulinemic vasculitis with renal involvement current possibilities of diagnostic and treatment
Milovanova S.Y., Kozlovskaya(Lysenko) L.V., Milovanova L.Y., Gordovskaya N.B., Ignatova T.M., Taranova M.V., Androsova T.V.
Diagnostic accuracy of predictive indexes of liver fibrosis in patients with chronic hepatitis C
Maev I.V., Kuznetsova E.I., Andreev D.N., Dicheva D.T.
Prediction of features of the course of chronic hepatitis C using Bayesian networks
Samokhodskaya L.M., Starostina E.E., Sulimov A.V., Krasnova T.N., Rosina T.P., Avdeev V.G., Savkin I.A., Sulimov V.B., Mukhin N.A., Tkachuk V.A., Sadovnichii V.A.
Predictors of the efficiency of short-term interferon-containing therapy using direct-acting antiviral drugs in patients with chronic hepatitis C virus genotype 1
Kokina K.Y., Bueverov A.O., Bogomolov P.O., Matsievich M.V.
The efficiency of antiviral therapy in patients with chronic hepatitis C infected with hepatitis C virus recombinants
Yushchuk N.D., Znoyko O.O., Dudina K.R., Kozina A.N., Kalininа O.V.
Topical problems of antiviral therapy for chronic hepatitis C
Bakulin I.G.
Catalase gene rs1001179 polymorphism and oxidative stress in patients with chronic hepatitis C and ulcerative colitis
Bulatova I.A., Tret'iakova I.I., Shchekotov V.V., Shchekotova A.P., Ulitina P.V., Krivtsov A.V., Nenasheva O.I.
Clinical features of chronic hepatitis B in the presence of metabolic syndrome and insulin resistance
Tkachenko L.I., Maleev V.V.
Significance of allelic variants of interleukin-28B gene in chronic hepatitis C
Tikhonova N.I., Burnevich É.Z., Krasnova T.N.
Hepatitis C virus Genotype 3: that "simple", yet that "complex"
Batskikh S.N., Morozov S.V., Chulanov V.P., Pokrovskiĭ V.I.
Regulators of fibrinolysis in chronic viral pathology of the liver
Yagoda A.V., Kopoy P.V., Yagoda A.V., Koroi P.V.
Evaluation of lipid peroxidation processes in patients with chronic parenteral viral hepatitis and HIV co-infection depending on degree of inflammatory process activity in the liver
Kolesnikova L.I., Darenskaya M.A., Kolesnikov S.I., Grebenkina L.A., Rashidova M.A., Timofeeva E.V., Leshenko O.Y., Nikitina O.A.
Myocardial injury associated with chronic hepatitis C: Clinical types and pathogenetic components
Strizhakov L.A., Karpov S.Y., Fomin V.V., Lopatkina T.N., Tanashchuk E.L., Taranova M.V.
Simeprevir in combination with pegylated interferon-α and ribavirin in the treatment of naïve patients with genotype 1 chronic hepatitis C
Burnevich É.Z.
Triple therapy for chronic hepatitis C: Practical Aspects
Bakulin I.G., Kiseleva A.V.
The clinical efficacy of a succinate-containing infusion drug during pharmacotherapy for hepatic lesions of varying genesis: results of meta-analysis
Mazina N.K., Mazin P.V., Sukhanov D.S.
EFFICACY OF COMBINED IMMUNOCORRECTION IN THE TREATMENT OF CHRONIC VIRAL HEPATITIS C
Frolov V.M., Sotskaya Y.A.
Clinical significance of intravital morphological investigation of the liver
Khomeriki S.G., Yakimchuk G.N., Golovanova E.V., Homeriki S.G., Yakimchuk G.N., Golovanova E.V.
Efficiency of using cycloferon as part of combined therapy for chronic hepatitis C (a review of multicenter clinical trials)
Sologub T.V., Romantsov M.G., Shul'dyakov A.A., Lin'kova Y.N., Radchenko V.G., Kovalenko A.L., Sologub T.V., Romantsov M.G., Shuldyakov A.A., Linkova Y.N., Radchenko V.G., Kovalenko A.L.
The role of systemic inflammation in the pathogenesis of insulin resistance and metabolic syndrome in patients with chronic hepatitis C
Tkachenko L.I., Maleev V.V.
Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2
Znoyko O.O., Dudina K.R., Kozina A.N., Kalininа O.V., Yushchuk N.D.
Chronic hepatitis C in Russia: current challenges and prospects
Chulanov V.P., Pimenov N.N., Mamonova N.A., Sagalova O.I., Shestakova I.V., Pokrovsky V.I.
Entecavir in the treatment of chronic hepatitis B: multicenter randomized trials and real clinical practice
Abdurakhmanov D.T., Otrashevskaia A.V.
Endothelial dysfunction markers (VCAM-1, vWF) in chronic hepatitis C
Antonova T.V., Romanova M.A., Lymar' I.V.
Telaprevir: New possibilities for antiviral treatment in patients with chronic hepatitis C
Nikitin I.G., Gogova L.M., Baĭkova I.E., Kisliakov V.A., Volynkina V.M.
The course and treatment of chronic hepatitis B in HIV-infected patients
Maksimov S.L., Tsarenko S.P., Kravchenko A.V., Yushchuk N.D., Maksimov S.L., Tsarenko S.P., Kravchenko A.V., Yushchuk N.D.
Activity an enzyme 5`-nucleotidase in patients with chronic hepatitis C
Galeeva N.V., Valeeva I.K.
Overexpression of DNA-methyltransferases in persistency of cccDNA pool in chronic hepatitis B
Kostyushev D.S., Zueva A.P., Brezgin S.A., Lipatnikov A.D., Simirskii V.N., Glebe D., Volchkova E.V., Shipulin G.A., Chulanov V.P.
Possibilities of using cepeginterferon alpha-2b in double (cepeginterferon alfa-2b and ribavirin) and triple (simeprevir, cepeginterferon alpha-2b, and ribavirin) antiviral therapy regimens for chronic hepatitis C. A review of clinical trials and experience of everyday clinical practice
Znoyko O.O., Klimova E.A., Maevskaya M.V., Shuldyakov А.A., Linkova Y.N., Morozova M.A.
Endothelial dysfunction gene polymorphisms and the rate of liver fibrosis in chronic hepatitis C
Taratina O.V., Krasnova T.N., Samokhodskaia L.M., Lopatkina T.N., Tkachuk V.A., Mukhin N.A.
Metabolic correctors based on siccine acid as pathogenic therapy in chronic virus hepatitis
Stel'makh V.V., Radchenko V.G., Kozlov V.K., Stelmakh V.V., Radchenko V.G., Kozlov V.K.
Metabolic syndrome and insulin resistance in patients with chronic hepatitis C
Bayzhanova Z.Z., Ignatova T.M., Nekrasova T.P., Baizhanova Z.Z., Ignatova T.M., Nekrasova T.P.
HBeAg-negative chronic hepatitis
Ibragimova M.M., Krel P.E., Abdurakhmanov D.T.
Disorders of carbohydrate-lipid metabolism and galectin-3 level as factors of liver fibrosis progression in chronic hepatitis C
Kovalevа V.A., Zhevnerova N.S., Antonova T.V.
HCV-associated mixed cryoglobulinemia and b-cell non-Hodgkin's lymphoma - pathogenetically related problems
Milovanova S.Y., Lysenko (Kozlovskaya) L.V., Milovanova L.Y., Mrykhin N.N., Russkih A.V., Muchin N.A.
Hepatitis C can be cured: will hepatitis B become next?
Chulanov V.P., Zueva A.P., Kostyushev D.S., Brezgin S.A., Volchkova E.V., Maleyev V.V.
Role of polymorphic markers for the genes of hemostasis and platelet receptors in liver fibrosis progression in patients with chronic hepatitis C
Starostina E.E., Samokhodskaya L.M., Rozina T.P., Krasnova T.N., Yarovaya E.B., Mukhin N.A.
Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C
Batskikh S.N., Karandashova I.V., Neverov A.D., Chulanov V.P.
The problem of viral hepatitis C in the Russian Federation
Iushchuk N.D., Znoĭko O.O., Dudina K.R., Belyĭ P.A.
Specific damage to the kidneys in patients with chronic hepatitis C associated with cryoglobulinemia
Milovanova S.Y., Tegay S.V., Russkikh A.V., Kozlovskaya L.V., Milovanova S.Y., Tegai S.V., Russkikh A.V., Kozlovskaya L.V.
HCV genome variability in acute and chronic viral hepatitis C
Yushchuk N.D., Klimova E.A., Znoyko O.O., Gadzhikulieva M.M., Il'ina E.N., Yashina T.L., Malyshev N.A., Tsyganova E.V., Yuschuk N.D., Klimova E.A., Znoiko O.O., Gadzhikulieva M.M., Ilyina E.N., Yashina T.L., Malyshev N.A., Tsyganova E.V.
1 - 50 of 66 Items 1 2 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies